poster

Pharmacokinetics of the three main alkaloids present in the South American psychoactive beverage Ayahuasca after oral administration to healthy volunteers

Thursday 16 October, 2025

Ayahuasca is a South American psychotropic plant tea used since pre- Columbian times in the Upper Amazon and Orinoco River…

Read more

Population pharmacokinetic/pharmacodynamic modeling of the possible tolerance development after a single oral dose of different BZD-GABAa agonists.

Thursday 16 October, 2025

Introduction: A commonly described situation for benzodiazepines (BZD) is the tolerance development after chronic administration. However, although many investigators have…

Read more

Metrics based on objective function for external validation of a population pharmacokinetic model

Thursday 16 October, 2025

PDF of poster Objectives: An important step in population pharmacokinetic model building is to evaluate the model’s adequacy. We propose…

Read more

Comparison of several prediction errors on concentrations for model evaluation

Thursday 16 October, 2025

PDF of poster objectives: The aim of this study is to compare criteria for the evaluation of a population pharmacokinetic…

Read more

Population pharmacokinetic analysis of indinavir in HIV-patients treated with a stable antiretroviral therapy

Thursday 16 October, 2025

Objectives: The objectives of this study were to build a population pharmacokinetic model that describes plasma concentrations of indinavir in…

Read more

A pooled population pharmacokinetic analysis of tesaglitazar in patients with type 2 diabetes or with manifestations of insulin resistance

Thursday 16 October, 2025

PDF of poster PDF of poster Objectives: Tesaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist under clinical development…

Read more

Pharmacokinetic and pharmacodynamic modelling of the dual PPAR α/γ agonist tesaglitazar in patients with manifestations of insulin resistance

Thursday 16 October, 2025

Objective: Tesaglitazar is a novel, dual peroxisome proliferator-activated receptor α/γ agonist under clinical development for the treatment of glucose and…

Read more

A disease model for the regulation of the glucose-insulin system

Thursday 16 October, 2025

PDF of poster Objectives: The aim of this project was to develop a mechanistic model to describe the glucose and…

Read more

PsN Toolkit, a collection of computer intensive methods for population PK/PD

Thursday 16 October, 2025

Objectives: Many computer intensive methods useful in model building and model validation have been described in the literature [1, 2]….

Read more

Symmetry and coverage of confidence intervals for a population PK model.

Thursday 16 October, 2025

Standard error estimates give an indication of the quality of model parameter estimates and are useful tools in hypothesis testing….

Read more